Lam Research Corporation $LRCX Shares Sold by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC lowered its holdings in Lam Research Corporation (NASDAQ:LRCX) by 15.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,307 shares of the semiconductor company’s stock after selling 14,934 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Lam Research were worth $14,260,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. PMV Capital Advisers LLC purchased a new stake in Lam Research in the 4th quarter valued at about $25,000. Stance Capital LLC purchased a new position in Lam Research during the third quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the second quarter valued at about $27,000. Triumph Capital Management purchased a new stake in shares of Lam Research in the 3rd quarter valued at approximately $27,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research in the 2nd quarter valued at approximately $29,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Price Performance

Lam Research stock opened at $211.41 on Friday. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $256.68. The firm has a market cap of $264.00 billion, a PE ratio of 43.32, a price-to-earnings-growth ratio of 2.27 and a beta of 1.77. The company’s 50 day moving average is $227.81 and its two-hundred day moving average is $181.88.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the firm posted $0.91 earnings per share. The company’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, research analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is presently 21.31%.

Insiders Place Their Bets

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares in the company, valued at $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 130,886 shares of company stock worth $29,658,802 in the last quarter. 0.31% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

LRCX has been the subject of a number of research analyst reports. TD Cowen increased their price objective on shares of Lam Research from $170.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. UBS Group set a $300.00 price target on Lam Research in a research note on Thursday, January 29th. Zacks Research upgraded Lam Research from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 20th. Needham & Company LLC lifted their price objective on Lam Research from $250.00 to $300.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $200.00 price objective (up from $175.00) on shares of Lam Research in a report on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $245.35.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.